Correlation Between NYSE Composite and Infinity Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Infinity Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Infinity Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Infinity Pharmaceuticals, you can compare the effects of market volatilities on NYSE Composite and Infinity Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Infinity Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Infinity Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Infinity Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Infinity is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Infinity Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Infinity Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Infinity Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Infinity Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Infinity Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Infinity Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.08 times more return on investment than Infinity Pharmaceuticals. However, NYSE Composite is 12.0 times less risky than Infinity Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Infinity Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest 1,556,254 in NYSE Composite on September 3, 2024 and sell it today you would earn a total of 470,950 from holding NYSE Composite or generate 30.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 30.91% |
Values | Daily Returns |
NYSE Composite vs. Infinity Pharmaceuticals
Performance |
Timeline |
NYSE Composite and Infinity Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Infinity Pharmaceuticals
Pair trading matchups for Infinity Pharmaceuticals
Pair Trading with NYSE Composite and Infinity Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Infinity Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Infinity Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infinity Pharmaceuticals will offset losses from the drop in Infinity Pharmaceuticals' long position.NYSE Composite vs. Lindblad Expeditions Holdings | NYSE Composite vs. LB Foster | NYSE Composite vs. HUTCHMED DRC | NYSE Composite vs. Bridgford Foods |
Infinity Pharmaceuticals vs. NextCure | Infinity Pharmaceuticals vs. Chimerix | Infinity Pharmaceuticals vs. Eledon Pharmaceuticals | Infinity Pharmaceuticals vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Bonds Directory Find actively traded corporate debentures issued by US companies |